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Abstract
Purpose The “Mars-500 project” allowed to evaluate the changes in psychological/physiological adaptation over a prolonged 
confinement, in order to gather information for future missions. Here, we evaluated the impact of confinement and isolation 
on body composition, glucose metabolism/insulin resistance and adipokine levels.
Methods The “Mars-500 project” consisted of 520 consecutive days of confinement from June 3, 2010 to Nov 4, 2011. The 
crew was composed of six male subjects (three Russians, two Europeans, and one Chinese) with a median age of 31 years 
(range 27–38 years).
Results During the 520-day confinement, total body mass and BMI progressively decreased, reaching a significant difference 
at the end (417 days) of the observation period (− 9.2 and − 5.5%, respectively). Fat mass remained unchanged. A progressive 
and significant increase of fasting plasma glucose was observed between 249 and 417 days (+ 10/+ 17% vs baseline), with 
a further increase at the end of confinement (up to + 30%). Median plasma insulin showed a non-significant early increment 
(60 days; + 86%). Total adiponectin halved (− 47%) 60 days after hatch closure, remaining at this nadir (− 51%) level for a 
further 60 days. High molecular weight adiponectin remained significantly lower from 60 to 168 days.
Conclusions Based on these data, countermeasures may be envisioned to balance the potentially harmful effects of prolonged 
confinement, including a better exercise program, with accurate monitoring of (1) the individual activity and (2) the relation-
ship between body composition and metabolic derangement.
Keywords Gender · Male · Chronic stress · Insulin resistance · Mars mission · "Mars-500 project" · Adiponectin
Introduction
Prolonged spaceflight for planetary exploration requires 
the ability of spacefarers to remain confined and isolated 
for a very long time. Within this context, the "Mars-500 
project" was organized by the European Space Agency 
(ESA) in close collaboration with the Institute for Biomedi-
cal Problems (IBMP; Moscow, Russia) as a simulation of 
an interplanetary voyage from the Earth to Mars and back. 
This unique experiment provided an outstanding opportunity 
to evaluate the changes in psychological and physiological 
adaptation over 520 days of confinement [1], by simulating 
the crew’s confinement, cohabitation and communication to 
Earth, along with the specific activities and workload taking 
place in these conditions [2].
Previous reports on the "Mars-500 project" described 
mood and sleep–wake changes [3, 4], as well as modifica-
tions of muscle strength [5] and autonomic nervous system 
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function [6] and of some circulating biomarker levels asso-
ciated with chronic environmental stress [3]. The potential 
body composition and metabolic changes associated with 
these psychological and physiological features have, how-
ever, not yet been reported.
This study opportunity appears novel, since only a 
few data on the impact of similarly extreme conditions in 
humans are available. Interestingly, people living in polar 
regions and exposed to both isolation–confinement and sub-
optimal light conditions, which make them comparable to 
subjects volunteering for the "Mars-500 project", were found 
to show insulin resistance [7]. Moreover, some information 
was collected in the previous 105-day isolation experiment, 
conducted within the frame of the "Mars-500 project", in 
the same setting, but with a different male cosmonaut team, 
which displayed some degree of insulin resistance and 
cortisol increase [8]. This experimental paradigm did not 
include exposure to microgravity and cosmic radiation, two 
important features of spaceflight [9–12], therefore making 
it closer (than true spaceflight) to on-Earth chronic stressful 
conditions that any individual may encounter.
Based on these premises, the present study was aimed at 
exploring whether the specific environmental conditions of 
the "Mars-500 project" may lead to a series of physiological 
adaptations related to body composition, glucose metabo-
lism/insulin resistance and circulating adipokine levels.
Methods
Study design–“Mars‑500 project”
The "Mars-500 project" consisted of 520 consecutive days 
of confinement from June 3, 2010 to Nov 4, 2011. The crew 
was composed of six male subjects (three Russians, two 
Europeans, and one Chinese) with a median age of 31 years 
(range 27–38 years). During the mission simulation, all of 
the crewmembers received the same diet, whose composi-
tion was almost identical to that one used in the International 
Space Station (ISS). The isolation facility, located at IBMP 
in Moscow, consisted of four hermetically sealed intercon-
nected 550 m3 habitat modules kept under artificial lighting 
conditions (50–300 lx) at a constant 24 °C temperature with 
a relative humidity of 35–45% and with normoxic, normo-
baric hypercapnia (0.15–0.65%  CO2), which is close to the 
parameters of the atmosphere of manned space objects, such 
as the ISS.
Water and food, which reflected the diet used in the ISS, 
were limited as in a real space flight. During the study, sub-
jects had free access to water, while caloric drinks, e.g., 
juices, were limited.
The energy intake was dependent on the subjects’ body 
weight and age and was calculated as follows [2]:
The meal plans included different types of food products, 
ready or semi-ready for consumption, by Russian, European, 
Korean, and Chinese firms, with up to four menu variants, 
providing an average 15.1% protein, 33.4% fat, and 51.2% 
carbohydrate [13].
Further information about all crewmembers and the 
whole project is available on the ESA website (http://www.
esa.int/Our_Activ ities /Human _Space fligh t/Mars-500/Scien 
tific _proto cols).
Clinical and anthropometric sampling
Height, body weight and body mass index of the six crew-
members were periodically recorded. After an overnight 
fast, subjects, wearing light clothes, were evaluated by dual-
energy X-ray absorptiometry (DXA) for body composition 
parameters, including total body mass, fat mass and lean 
mass.
Biochemical and hormonal sampling
After an overnight fast, 7 mL of blood samples was drawn 
into blood tubes containing EDTA as anticoagulant between 
7 and 8 am in the morning. Plasma samples were transferred 
into new tubes as 500 mL aliquots and kept at − 20 °C. 
Baseline data samples were collected 7 days before the 
beginning of the isolation. The sampling time points were 
day 60, 120, 168, 249, 300, 360, 418, 510 and 7 days after 
the confinement. Two crewmembers with medical training 
were in charge of blood sampling. Total cholesterol, HDL 
cholesterol, triglycerides and fasting plasma glucose (FPG) 
were measured by standard enzymatic techniques (Cobas 
600 analyzer, Roche, USA). Frozen samples were assayed 
immediately after thawing by means of commercially avail-
able enzyme-immuno-assays (ELISA), which have been pre-
viously validated in our laboratory and used in published 
studies [14, 15]. Plasma leptin ELISA (R&D Systems, MN, 
USA) showed a minimum detectable dose of 7.8 pg/mL and 
inter-assay and intra-assay coefficient of variations (CV) was 
5.4 and 3.3%, respectively.
Plasma total adiponectin ELISA (R&D Systems, MN, 
USA) showed a minimum detectable concentration of 
0.891 ng/mL and inter-assay and intra-assay CV was 3.4 and 
4.7%, respectively. Plasma high molecular weight (HMW) 
Age 18−30years ∶ kilocalories (kcal∕day)
= 1.7 × (15.3 × body weight + 679),
Age > 30years ∶ kilocalories (kcal∕day)
= 1.7 × (11.6 × body weight + 879).
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adiponectin ELISA (R&D Systems) showed a minimum 
detectable concentration of 0.98 ng/mL and inter-assay and 
intra-assay CV were 8.6 and 3.6%, respectively.
Plasma insulin ELISA (Millipore Corporation, MA, USA) 
had a minimum detectable concentration of 2 mU/mL and 
inter-assay and intra-assay CV was 9.1–11.4 and 4.6–7.0%, 
respectively. The homeostasis model assessment of insulin 
resistance (HOMA-IR) score was calculated as follows: fast-
ing insulin, μU/mL × fasting glucose, mmol/L]/22.5 [16].
Statistical analysis
For descriptive statistics, results are presented as median, 
interquartile ranges (Q1 and Q3) for all parameters. Nor-
mality was assessed by the Kolmogorov–Smirnov test; 
since no variables reached this assumption Friedman test 
was applied as a non-parametric alternative to the one-way 
ANOVA with repeated measures. Sums of ranks and the 
sample sizes were taken into consideration. When repeated 
measures were significant, Dunn’s multiple comparison 
test was applied to compare the mean rank of each time 
point with the mean rank of baseline. We set the criterion 
for statistical significance at 5%. Data were analyzed using 
the SAS System Software for Windows, release 8.0 (SAS 
Institute, NC, USA).
Results
Clinical and biochemical features of the study 
subjects
All six male crewmembers successfully completed the 
entire 520-day isolation experiment, showing no major 
clinically appreciable pathological changes. The anthro-
pometric and biochemical features of the six participants 
are summarized in Table 1. The total body mass range was 
72.0–98.0 kg (median 81.5 kg) corresponding to a BMI 
range of 23.0–31.3 kg/m2 (median 25.5 kg/m2) and a fat 
mass range of 2.4–17.8 kg (median 11.1 kg). All subjects 
showed normal baseline metabolic biomarkers.
Anthropometric and metabolic parameters 
over the 520‑day confinement
To further investigate the effect of long-term confinement 
over the entire course of the simulation, the parameters 
reported in Table 1 were evaluated, performing a non-para-
metric Friedman test (Tables 2, 3, 4). As shown in Table 2, 
total body mass and BMI progressively decreased over time, 
reaching a significant difference only at the end (417 days) 
of the observation period (− 9.2 and − 5.5%, respectively; 
all p < 0.01). Such total body mass reduction can be attrib-
uted to a decrease of lean mass (− 12% at 417- vs. − 7-day; 
p < 0.01), without significant changes of fat mass (Table 2). 
Comparison of the body mass changes of the crewmembers 
during the Mars-500 experiment and at the end of the mis-
sion simulation indicated that one subject (#5002) displayed 
a significant reduction in body mass (− 21 kg). For the other 
subjects, the reduction was lower (subjects #5003, #5004, 
#5005, #5006, from − 4 to − 11 kg) or negligible (subject 
#5001, − 1 kg).
A moderate, but progressive, increase of FPG was 
observed between 249 and 417 days, with a further increase 
in the last part of the confinement period. Specifically, 
median FPG was significantly elevated and ranged from 99.8 
to 108.5 mg/dL (Table 3). The median values of plasma 
insulin showed a non-significant early increment (60-day; 
+ 86%), which was steadily maintained up to the end of 
confinement. A similar profile was observed also for the 
HOMA-IR (60 days; + 67%).
No changes were found in lipid profile parameters (data 
not shown). Changes of plasma leptin and total and HMW 
adiponectin, the two main adipokines, were evaluated 
(Table 4). Over the entire observation period, no significant 
changes in leptin levels were observed. Total adiponectin 
approximately halved 60 days after the hatch closure (− 47%, 
p < 0.05), remaining at this nadir level for a further 60 days. 
It then progressively returned to baseline levels around the 
end of the isolation period. A similar profile was observed 
for HMW adiponectin, which remained significantly lower 
from 60 to 168 days. The leptin/adiponectin ratio tripled at 
60 days and progressively decreased down to the baseline 
values at 520 days.
Table 1  Clinical and biochemical features of the study subjects 
(n = 6) at baseline (7 days before the isolation)
BMI body mass index, FPG fasting plasma glucose, HOMA-IR the 
homeostasis model assessment insulin resistance, HMW high molecu-
lar weight, Q1 25% percentile, Q2 75% percentile
7 days before the isolation
Median Q1 Q3 Range
Total body mass (kg) 81.5 74.2 90.5 72.0–98.0
Lean mass (kg) 71.3 65.5 78.3 62.7–80.2
Fat mass (kg) 11.1 7.6 15.3 2.4–17.8
BMI (kg/m2) 26.0 23.7 28.9 23.0–31.3
FPG (mg/dL) 83.7 75.3 85.9 70.1–87.3
Insulin (mU/L) 2.79 1.61 7.31 1.10–8.80
HOMA-IR 0.58 0.30 1.59 0.23–1.75
Adiponectin (µg/mL) 6.79 6.30 8.39 6.10–8.50
HMW adiponectin (µg/mL) 4.06 3.61 4.56 3.47–4.58
Leptin (ng/mL) 6.36 4.74 15.3 4.01–17.7
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Discussion
Focusing on body composition changes and metabolic 
derangements, the present study aimed at extending to 
this important field the available information on simulated 
flight to Mars within the "Mars-500 project". Moreover, 
the findings of such an extreme experiment, based on 
prolonged chronic stress, appear to have a relevant clini-
cal value, since they identified changes of biomarkers 
associated with glucose and energy metabolism, which 
are in turn related to risk of cardiovascular and endo-
crine–metabolic diseases [1]. The main findings show that 
520 days of confinement and cohabitation led to progres-
sive body mass and lean mass reduction and to moderate 
insulin resistance and earlier adiponectin reduction. Inter-
estingly, we observed a significant reduction of body mass 
and BMI, which mainly derive from a reduction of lean 
mass rather than fat mass. The pathophysiology of such a 
complex process may be multifactorial.
During the 520-day isolation, some sleep–wake altera-
tions were reported and a relevant and prolonged chronic 
stress has been described [4, 17, 18], which may have pro-
duced potential effects on the circadian dynamics of some 
Table 2  Anthropometric parameters evaluated at different time points 
of the "Mars-500 project"
BMI body mass index, Q1 25% percentile, Q2 75% percentile
**p < 0.01 (Dunn’s multiple comparison for time)
Independent variable Time (day) Median Q1 Q3 p
BMI (kg/m2)
Friedman’s test: p < 0.001
− 7 26.0 23.7 28.9 –
60 26.5 25.1 28.3 ns
119 26.3 24.9 27.3 ns
168 25.5 24.5 26.6 ns
249 25.9 24.0 27.4 ns
280 25.5 24.1 26.9 ns
301 25.4 23.6 26.2 ns
361 25.5 24.5 25.9 ns
417 24.6 22.6 25.1 **
Total body mass (kg)
Friedman’s test: p < 0.001
− 7 81.5 74.2 90.5 –
60 83.1 78.5 88.7 ns
119 82.5 78.8 85.7 ns
168 80.0 76.7 83.4 ns
249 81.3 75.2 84.3 ns
280 79.7 75.5 82.1 ns
301 79.5 74.0 81.2 ns
361 80.0 74.5 81.4 ns
417 74.0 56.1 78.5 **
Lean mass (kg)
Friedman’s test: p < 0.001
− 7 71.3 65.6 78.3 –
60 71.3 66.8 75.3 ns
119 68.8 64.9 75.8 ns
168 70.4 62.3 73.2 ns
249 68.3 62.9 73.7 ns
280 71.5 63.7 75.4 ns
301 69.4 60.1 74.7 ns
361 70.1 63.9 73.3 ns
417 62.9 51.8 69.9 **
Fat mass (kg)
Friedman’s test: ns
− 7 11.1 7.6 15.3 –
60 10.4 7.8 18.5 ns
119 12.3 8.7 16.9 ns
168 9.60 7.6 17.2 ns
249 9.50 7.2 17.3 ns
280 5.60 3.5 15.3 ns
301 7.90 4.7 16.5 ns
361 6.45 5.4 13.9 ns
417 10.1 4.9 17.4 ns
Table 3  Glucose parameters evaluated at different time points of the 
"Mars-500 project"
FPG fasting plasma glucose, HOMA-IR the homeostasis model 
assessment insulin resistance, Q1 25% percentile, Q2 75% percentile
*p < 0.05 and ***p < 0.001 (Dunn’s multiple comparison for time)




− 7 83.7 78.0 85.1 –
60 82.4 69.1 88.8 ns
119 78.8 76.8 88.1 ns
168 80.3 75.0 83.2 ns
249 91.7 88.3 98.6 ns
301 97.9 97.1 103.2 ns
361 95.9 89.8 98.6 ns
417 95.6 91.6 98.3 ns
511 108.5 103.6 110.5 ***
518 99.8 91.4 105.2 *
Insulin (mU/L)
Friedman’s test: ns
− 7 2.8 1.9 7.3 –
60 5.2 3.1 9.4 ns
119 4.3 2.4 7.3 ns
168 7.2 3.6 9.3 ns
249 6.7 3.4 8.8 ns
301 9.2 2.4 10.2 ns
361 6.4 4.9 11.9 ns
417 6.8 1.3 11.8 ns
511 6.5 3.1 10.0 ns
518 4.0 1.7 7.9 ns
HOMA-IR
Friedman’s test: p < 0.05
− 7 0.6 0.3 1.5 –
60 1.0 0.6 2.1 ns
119 0.9 0.5 1.5 ns
168 1.4 0.7 1.9 ns
249 1.6 0.8 2.0 ns
301 2.2 0.6 2.6 ns
361 1.5 1.1 2.8 ns
417 1.7 0.3 2.6 ns
511 1.8 0.8 2.6 ns
518 1.0 0.4 1.9 ns
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hormonal secretions (i.e., growth hormone, cortisol) known 
to impact on body composition. Indeed, a high salivary cor-
tisol has been reported in the same crewmembers during 
the whole isolation period [18, 19]. Moreover, in these sub-
jects, qualitative and quantitative changes of food ingestion 
could also have occurred, due to these and other alterations 
reported, i.e., diminished amplitude of the circadian rhythm 
of the parasympathetic autonomic nervous system [6] and 
a rise in serotonin and norepinephrine [3]. In addition, the 
sedentariness of the crewmembers increased across this 
simulated mission; a relevant hypokinesis occurred due to 
the increased sleep and rest times [4].
Adipokines, including leptin and adiponectin, are 
involved in the regulation of a wide variety of physiological 
processes including insulin responsiveness, glucose and lipid 
metabolism [20–23]. Leptin has also been shown to recipro-
cally interact with insulin in physiological and pathological 
conditions, is positively correlated with insulin resistance 
[24, 25] and shows a marked gender dimorphism [26, 27].
Adiponectin is an abundant adipokine secreted by the 
adipose tissue, with anti-inflammatory, antiatherogenic and 
cardioprotective properties. Adiponectin and especially its 
HMW form is a potent insulin sensitizer in muscle and liver, 
regulating energy homeostasis and glucose tolerance [28]. 
Adiponectin levels are inversely related to insulin resistance, 
and reduced adiponectin levels are linked with insulin resist-
ance-associated conditions and greater vascular damage 
[29]. In our six male volunteers, plasma leptin levels did not 
change during the entire confinement period. Interestingly, 
in the early phase of the long-term isolation, a significant 
decrement of total and HMW adiponectin was observed. 
Various studies have shown that the ratio of plasma leptin to 
adiponectin (L:A ratio) is a better surrogate marker for insu-
lin resistance compared to these values assessed individu-
ally [30–33]. Although in a non-significant way, our data 
show that L:A ratio showed a threefold increase at 60 days 
and progressively decreased to baseline values at the end of 
the confinement period. Of note, at 60 days, the L:A ratio 
positively correlate with insulin (r2 = 0.917, p = 0.010) and 
HOMA-IR (r2 = 0.953, p = 0.003). In this context, a study 
reported how the L:A ratio may be more powerful than 
HOMA-IR for evaluating insulin resistance in subjects with 
or without hyperglycemia [25].
The evaluation of insulin resistance allowed us to observe 
that, after the half of the experiment duration, FPG started 
to increase as a consequence of the development of insulin 
resistance, with insulin and HOMA-IR peaking at 301 days. 
In any case, increased insulin secretion in these healthy sub-
jects appears sufficient to keep FPG within the normal range, 
although close to the upper limit of 100 mg/dL and in some 
instances even slightly above this value, which is nowadays 
diagnostic of impaired fasting glucose, i.e., a reversible 
pre-diabetic condition. A modest derangement of FPG was 
observed also in the 105-day simulated Mars mission [8], 
but in this situation confinement produced an FPG increase 
during the first 5 weeks without indications of development 
of insulin resistance, probably because the observation time 
was too short to elicit such phenomenon in young healthy 
Table 4  Hormonal parameters evaluated at different time points of 
the “Mars-500 project”
HMW high molecular weight, Q1 25% percentile, Q2 75% percentile
*p < 0.05 and **p < 0.01 (Dunn’s multiple comparison for time)
Independent variable Time (day) Median Q1 Q3 p
Adiponectin (µg/mL)
Friedman’s test: p < 0.001
− 7 6.8 6.4 8.3 –
60 3.6 2.9 4.7 *
119 3.3 2.4 3.9 *
168 4.0 3.1 4.7 ns
249 4.5 3.5 6.6 ns
301 5.2 4.3 6.5 ns
361 5.0 3.8 7.8 ns
417 7.0 5.1 9.0 ns
511 7.6 5.2 9.0 ns
518 8.3 6.2 8.8 ns
HMW adiponectin (µg/mL)
Friedman’s test: p < 0.0001
− 7 4.1 3.7 4.6 –
60 1.6 1.2 2.7 **
119 1.6 1.0 2.0 **
168 1.9 1.5 3.0 *
249 2.2 1.9 3.2 ns
301 2.5 2.1 3.4 ns
361 2.9 2.4 3.2 ns
417 3.5 2.2 4.7 ns
511 3.8 3.2 4.2 ns
518 4.4 3.6 5.6 ns
Leptin (ng/mL)
Friedman’s test: ns
− 7 6.4 5.1 14.2 –
60 12.7 5.9 15.3 ns
119 6.2 5.1 12.9 ns
168 8.6 4.8 16.9 ns
249 5.7 3.5 16.4 ns
301 6.8 3.5 15.3 ns
361 6.1 4.0 14.2 ns
417 5.6 3.4 13.2 ns
511 5.4 2.7 11.1 ns
518 6.8 3.9 10.0 ns
Leptin/adiponectin
Friedman’s test: p < 0.001
− 7 1.0 0.8 1.7 –
60 3.1 1.9 4.2 ns
119 2.4 1.4 3.7 ns
168 2.4 2.0 3.5 ns
249 1.3 1.0 2.5 ns
301 1.6 0.6 2.7 ns
361 1.4 0.8 2.0 ns
417 1.0 0.5 2.1 ns
511 1.0 0.3 1.4 ns
518 0.9 0.6 1.4 ns
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subjects. Interestingly, some contribution to insulin resist-
ance may also derive from skeletal muscle changes, which 
have recently been described in the participants to the Mars-
500 experiment [5]. Moreover, some degree of insulin resist-
ance seems a common feature of conditions comparable to 
the 520-day isolation/confinement, such as, for example, 
people living in polar regions [7].
Additional factors may have also contributed to the devel-
opment of subtle cardiovascular [1] and metabolic altera-
tions in the 520-day experiment subjects, who were oth-
erwise healthy. Interestingly, they have been found to have 
some degree of intestinal inflammation [34], although a con-
tribution by changes in gut microbiome has been excluded in 
the participants of the "Mars-500 project" [13].
A limitation of this study is that, since only male subjects 
were included in the "Mars-500 project", we could not evalu-
ate the impact of such prolonged chronic stressful condi-
tions on female metabolism and body composition. Since 
women show peculiar endocrine and metabolic features, 
as well as a very different body composition than men, it 
will be very important to conduct similar studies also in the 
female gender. As mentioned before, microgravity and cos-
mic radiation, two crucial aspects of spaceflight with major 
health impact [9–11], were not included in the design of the 
"Mars-500 project". Apparently a limitation, this condition 
conversely allowed to dissect out the specific contribution 
of confinement, cohabitation and (delayed) communication 
to Earth to psychological and physiological features, includ-
ing the data presented in this paper. Future studies bearing 
a greater level of complexity should combine all the com-
ponents of a challenging space flight as that from Earth to 
Mars, before a manned mission will reach the Red Planet.
On the basis of the data obtained, it is possible to envi-
sion a series of countermeasures to balance the potentially 
harmful effects observed, to be applied both to the very 
restricted field of prolonged spaceflight, as well as to peo-
ple subjected to chronic stress. Specifically, a well-focused 
exercise program, with accurate monitoring of the actual 
individual activity and of the relationship between body 
composition and metabolic derangement, may be useful 
[35]. Moreover, it might be important to promote improve-
ments of nutrition monitoring and sleep–wake cycle, as 
well as an accurate evaluation of the individual cardio-
vascular and metabolic risk in cosmonauts directed to 
Mars (i.e., accurate selection of crewmembers, in-flight 
monitoring of related biomarkers and arterial wall thick-
ness), but also, with a much broader view, in selected sub-
jects exposed (or to be exposed) to relevant and prolonged 
chronic stress conditions.
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